Article By:
Scott Matusow
Thursday, December 4, 2014 2:06 PM EDT
Investor Joseph Edelman leads Perceptive Advisors and since 1999 the fund has returned an annualized 30.2%. Last year, the fund returned about 48%. Edelman works with six biotech analysts to find companies with potential large gains ahead.